Sex differences are well recognized in thrombotic diseases, but the underlying mechanisms remain unclear. The sodium/potassium ATPase (NKA), composed of α and β subunits, regulates ion homeostasis and plays a key role in cardiovascular function. We investigated whether the NKA α1 subunit influences platelet activation and thrombosis. Using the ferric chloride (FeCl3)–induced carotid artery injury thrombosis model in wild-type (WT; α1+/+) and NKA α1 heterozygous (α1+/−) mice, we found that NKA α1 haploinsufficiency significantly inhibited thrombosis in males but not in females, without affecting hemostasis. Platelet NKA α1 expression was halved in α1+/− mice, but sodium homeostasis remained unchanged. Transfusion of α1+/− platelets into thrombocytopenic WT mice prolonged the time to occlusive thrombus formation. Low-dose ouabain or marinobufagenin, which bind NKA α1, suppressed thrombosis. Mechanistically, α1 interacted with P2Y12, and this interaction was disrupted by a leucine-glycine-leucine (LGL)→serine-phenylalanine-threonine mutation in either partner or by the LGL peptide. NKA α1 haploinsufficiency, ouabain, and LGL peptide treatment all reduced ADP-induced platelet aggregation. Female mice exhibited higher platelet α1 expression and shorter thrombosis times than males. Gonadectomy had no effect in females but abolished the antithrombotic phenotype in α1+/– males, whereas orchiectomy increased platelet α1 expression. Although α1 haploinsufficiency did not affect thrombosis in the 10% FeCl3 model, it prolonged thrombosis time in mice treated with low-dose clopidogrel or prasugrel, which alone had no effect. These findings identify NKA α1 as a key regulator of sex-specific platelet activation and thrombosis, suggesting its potential as a biomarker for thrombotic risk and a therapeutic target for antiplatelet and antithrombotic therapy.
7 January 2026 in Clinical Pharmacology & Therapeutics
Students and trainees are integral to clinical pharmacology, as they have the potential to shape the field. This perspective highlights how the ASCPT Student and Trainee Community engages members worldwide, providing opportunities and resources to advance scientific and professional development. It also discusses strategies to foster equitable access and how these efforts promote pharmacoequity, including peer mentorship, international engagement, fair access to leadership roles, and diverse representation.